(Q34515354)

2 August 2017

1 reference

title

Prospects for the treatment of Parkinson's disease using neurotrophic factors (English)

1 reference

2 August 2017

1 reference

Hurelbrink CB

1

1 reference

2 August 2017

Barker RA

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1531-1543

1 reference

Prospects for the treatment of Parkinson's disease using neural grafts

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

21 January 2018

Neurotrophic molecules

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Neurturin enhances the survival of intrastriatal fetal dopaminergic transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Persephin, a novel neurotrophic factor related to GDNF and neurturin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Clinical observations after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Development of fetal neural transplantation as a treatment for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Development of dopaminergic neurons in the human mesencephalon and in vitro effects of basic fibroblast growth factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Ganglioside treatment in the recovery of the DA nigrostriatal system in different experimental conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.10.1531

10.1517/14656566.2.10.1531

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference